Nymox Pharmaceutical Corporation Soared
Fri, Dec 31, 2021 at 05:30 PM
Nymox Pharmaceutical Corporation (NYMX:NASDAQ) shot up at $1.3, representing a gain of 37%. On Thu, Dec 30, 2021, NYMX:NASDAQ touched a New 2-Week Low of $0.95. From Thu, Dec 16, 2021, the stock recorded 11.11% Up Days and 40.00% Green Days
About Nymox Pharmaceutical Corporation (NYMX:NASDAQ)
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Top 10 Gainers:
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 85.09%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 37%
- UCL (UCL:NASDAQ), 32.33%
- PolarityTE, Inc. (PTE:NASDAQ), 31%
- LVTX (LVTX:NASDAQ), 30.02%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 26.14%
- CPOP (CPOP:NASDAQ), 25.61%
- FATH (FATH:NYSE), 22.22%
- Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 22.12%
- PEAR (PEAR:NASDAQ), 22.05%